Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.71
- Piotroski Score 3.00
- Grade Overweight
- Symbol (PRGO)
- Company Perrigo Company plc
- Price $28.08
- Changes Percentage (3.69%)
- Change $1
- Day Low $26.96
- Day High $28.12
- Year High $34.60
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
- Last Earnings 11/01/2024
- Ex-Dividend for 5/16 Dividend 11/29/2024
- Dividend Payable 12/17/2024
- Today N/A
- Next Earnings (Estimated) 02/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $42.00
- High Stock Price Target $54.00
- Low Stock Price Target $30.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.01
- Trailing P/E Ratio 2694
- Forward P/E Ratio 2694
- P/E Growth 2694
- Net Income $-12,700,000
Income Statement
Quarterly
Annual
Latest News of PRGO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Perrigo Co PLC (PRGO) Q3 2024 Earnings Call Highlights: Strategic Savings and EPS Growth Amid ...
Opill is experiencing growth in awareness and trial rates, focusing on in-store visibility and key user groups. Cash outflows from restructuring programs are better than expected, allowing for reinves...
By Yahoo! Finance | 2 weeks ago -
Perrigo Company plc (PRGO): Leading OTC Health Products with Strong Growth in Infant Formula
Analysts anticipate earnings to offset market volatility amid elections. Alan McKnight from Regions Wealth Management sees positive trends in recent data, emphasizing strong consumer spending over rat...
By Yahoo! Finance | 4 weeks ago -
Perrigo Company plc (PRGO): Among the Best Mid-Cap Healthcare Stocks To Buy Now
A compilation of the 10 Best Mid-Cap Healthcare Stocks To Buy Now includes a focus on Perrigo Company plc (NYSE:PRGO). The healthcare market is projected to grow significantly, driven by segments like...
By Yahoo! Finance | 2 months ago
